These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
162 related items for PubMed ID: 6574267
1. Spontaneous tumor cell killing by human blood monocytes and human peritoneal macrophages: lack of alteration by endotoxin or quenchers of reactive oxygen species. Weinberg JB, Haney AF. J Natl Cancer Inst; 1983 Jun; 70(6):1005-10. PubMed ID: 6574267 [Abstract] [Full Text] [Related]
2. Rapid killing of actinomycin D-treated tumor cells by human monocytes. II. Cytotoxicity is independent of secretion of reactive oxygen intermediates and is suppressed by protease inhibitors. Colotta F, Bersani L, Lazzarin A, Poli G, Mantovani A. J Immunol; 1985 May; 134(5):3524-31. PubMed ID: 4038989 [Abstract] [Full Text] [Related]
3. Lysis of tumor cells by human blood monocytes by a mechanism independent of activation of the oxidative burst. Kleinerman ES, Ceccorulli LM, Bonvini E, Zicht R, Gallin JI. Cancer Res; 1985 May; 45(5):2058-64. PubMed ID: 2985242 [Abstract] [Full Text] [Related]
4. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage. Colotta F, Peri G, Villa A, Mantovani A. J Immunol; 1984 Feb; 132(2):936-44. PubMed ID: 6690624 [Abstract] [Full Text] [Related]
5. Human monocyte-mediated tumor cytotoxicity. I. Demonstration of an oxygen-dependent myeloperoxidase-independent mechanism. Mavier P, Edgington TS. J Immunol; 1984 Apr; 132(4):1980-6. PubMed ID: 6321594 [Abstract] [Full Text] [Related]
6. Changes in mechanisms of monocyte/macrophage-mediated cytotoxicity during culture. Reactive oxygen intermediates are involved in monocyte-mediated cytotoxicity, whereas reactive nitrogen intermediates are employed by macrophages in tumor cell killing. Martin JH, Edwards SW. J Immunol; 1993 Apr 15; 150(8 Pt 1):3478-86. PubMed ID: 8385686 [Abstract] [Full Text] [Related]
7. Differences in antibody-dependent cellular cytotoxicity and activated killing of tumor cells by macrophage cell lines. Ralph P, Nakoinz I. Cancer Res; 1981 Sep 15; 41(9 Pt 1):3546-50. PubMed ID: 6973392 [Abstract] [Full Text] [Related]
8. Human macrophage differentiation in vivo and in vitro. A comparison of human peritoneal macrophages and monocytes. Hammerstrøm J. Acta Pathol Microbiol Scand C; 1979 Apr 15; 87C(2):113-20. PubMed ID: 375676 [Abstract] [Full Text] [Related]
9. Induction of reactive oxygen intermediates in human monocytes by tumour cells and their role in spontaneous monocyte cytotoxicity. Mytar B, Siedlar M, Wołoszyn M, Ruggiero I, Pryjma J, Zembala M. Br J Cancer; 1999 Feb 15; 79(5-6):737-43. PubMed ID: 10070862 [Abstract] [Full Text] [Related]
10. The effects of phorbol ester activation and reactive oxygen species scavengers on the macrophage-mediated foreign body reaction to polyurethanes. McBane JE, Matheson LA, Santerre JP, Labow RS. J Biomed Mater Res A; 2009 Dec 15; 91(4):1150-9. PubMed ID: 19148928 [Abstract] [Full Text] [Related]
14. Effect of catalase on the proliferation of human lymphocytes to phorbol myristate acetate. Sagone AL, Husney R, Guter H, Clark L. J Immunol; 1984 Sep 15; 133(3):1488-94. PubMed ID: 6747295 [Abstract] [Full Text] [Related]
16. IL-2 enhances standard IFNgamma/LPS activation of macrophage cytotoxicity to human ovarian carcinoma in vitro: a potential for adoptive cellular immunotherapy. Han X, Wilbanks GD, Devaja O, Ruperelia V, Raju KS. Gynecol Oncol; 1999 Nov 15; 75(2):198-210. PubMed ID: 10525372 [Abstract] [Full Text] [Related]
17. Blood monocytes and tumor-associated macrophages in human cancer: differences in activation levels. Baskic D, Acimovic L, Samardzic G, Vujanovic NL, Arsenijevic NN. Neoplasma; 2001 Nov 15; 48(3):169-74. PubMed ID: 11583284 [Abstract] [Full Text] [Related]
18. Induction of chemiluminescence during interaction of tumoricidal effector cell populations and tumor cells is dependent on the presence of mycoplasma. Köppel P, Peterhans E, Bertoni G, Keist R, Groscurth P, Wyler R, Keller R. J Immunol; 1984 Apr 15; 132(4):2021-9. PubMed ID: 6607953 [Abstract] [Full Text] [Related]